Here's a Quick Look Into the Fundamentals of Bain Capital Specialty Finance Stock

By Tamara Parker • Monday, May 08 09:45 • Permanent Link

Join us for a quick overview of Bain Capital Specialty Finance, a Diversified financial company whose shares moved 0.4% today. Here are some facts about the stock that should help you see the bigger picture:

Bain Capital Specialty Finance has moved -25.3% over the last year, and the S&P 500 logged a change of 3.6%
BCSF has an average analyst rating of hold and is -13.18% away from its mean target price of $13.13 per share
Its trailing earnings per share (EPS) is $1.63
Bain Capital Specialty Finance has a trailing 12 month Price to Earnings (P/E) ratio of 7.0 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $1.67 and its forward P/E ratio is 6.8
The company has a Price to Book (P/B) ratio of 0.66 in contrast to the S&P 500's average ratio of 2.95
Bain Capital Specialty Finance is part of the Finance sector, which has an average P/E ratio of 14.34 and an average P/B of 1.57
BCSF has reported YOY quarterly earnings growth of 95.3% and gross profit margins of 1.0%
The company has a free cash flow of $123.7 Million, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.